Globus Medical Asset Resilience Ratio
Globus Medical asset resilience ratio. Globus Medical (GMED) has an Asset Resilience Ratio of 1.59% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Globus Medical defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Globus Medical (2012–2025)
Asset resilience ratio of Globus Medical from 2012 to 2025. This chart shows how Globus Medical's Asset Resilience Ratio has changed over time. Read GMED current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Globus Medical's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Globus Medical (GMED) total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $87.40 Million | 1.59% |
| Total Liquid Assets | $87.40 Million | 1.59% |
Asset Resilience Insights
- Limited Liquidity: Globus Medical maintains only 1.59% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Globus Medical Industry Peers by Asset Resilience Ratio
Compare Globus Medical's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Applied BioCode
TW:6598 |
Medical Devices | 9.75% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Radiant Innovation
TWO:3373 |
Medical Devices | 0.82% |
|
Impedimed Ltd
AU:IPD |
Medical Devices | 46.15% |
|
Memphasys Ltd
AU:MEM |
Medical Devices | 0.00% |
Globus Medical Asset Resilience Ratio by Year (2012–2025)
Globus Medical asset resilience ratio by year from 2012 to 2025. The table below shows the annual Asset Resilience Ratio data for Globus Medical.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.59% | $31.09 Million | $5.30 Billion | -1.42pp |
| 2024-12-31 | 2.01% | $105.62 Million | $5.25 Billion | +1.02pp |
| 2023-12-31 | 0.99% | $50.50 Million | $5.09 Billion | -13.24pp |
| 2022-12-31 | 14.24% | $295.59 Million | $2.08 Billion | +1.45pp |
| 2021-12-31 | 12.79% | $250.38 Million | $1.96 Billion | +1.64pp |
| 2020-12-31 | 11.15% | $187.34 Million | $1.68 Billion | +3.60pp |
| 2019-12-31 | 7.56% | $115.76 Million | $1.53 Billion | -7.82pp |
| 2018-12-31 | 15.37% | $199.94 Million | $1.30 Billion | -8.26pp |
| 2017-12-31 | 23.63% | $254.89 Million | $1.08 Billion | -0.44pp |
| 2016-12-31 | 24.08% | $223.36 Million | $927.64 Million | -2.40pp |
| 2015-12-31 | 26.48% | $220.88 Million | $834.10 Million | +5.67pp |
| 2014-12-31 | 20.81% | $146.44 Million | $703.55 Million | -5.49pp |
| 2013-12-31 | 26.30% | $148.96 Million | $566.30 Million | -- |
| 2012-12-31 | 0.00% | $0.00 | $447.13 Million | -- |
About Globus Medical
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting… Read more